adult-combined-schedule.pdf

Recommended Adult Immunization Schedule UNITED STATES 2024 for ages 19 years or older Vaccines in the Adult Immunization Schedule* Vaccine How to use the adult immunization schedule Abbreviation(s) Trade name(s) 1vCOV-mRNA Comirnaty®/Pfizer-BioNTech COVID-19 Vaccine Spikevax®/Moderna COVID-19 Vaccin...

Recommended Adult Immunization Schedule UNITED STATES 2024 for ages 19 years or older Vaccines in the Adult Immunization Schedule* Vaccine How to use the adult immunization schedule Abbreviation(s) Trade name(s) 1vCOV-mRNA Comirnaty®/Pfizer-BioNTech COVID-19 Vaccine Spikevax®/Moderna COVID-19 Vaccine 1vCOV-aPS Novavax COVID-19 Vaccine Haemophilus influenzae type b vaccine Hib ActHIB® Hiberix® PedvaxHIB® Hepatitis A vaccine HepA Havrix® Vaqta® Hepatitis A and hepatitis B vaccine HepA-HepB Twinrix® Hepatitis B vaccine HepB Engerix-B® Heplisav-B® PreHevbrio® Recombivax HB® Human papillomavirus vaccine HPV Gardasil 9® Influenza vaccine (inactivated) IIV4 Many brands Influenza vaccine (live, attenuated) LAIV4 FluMist® Quadrivalent Influenza vaccine (recombinant) RIV4 Flublok® Quadrivalent Report Measles, mumps, and rubella vaccine MMR M-M-R II® Priorix® y Clinically significant adverse events to the Vaccine Adverse Event Reporting System at Meningococcal serogroups A, C, W, Y vaccine MenACWY-CRM MenACWY-TT Menveo® MenQuadfi® Meningococcal serogroup B vaccine MenB-4C MenB-FHbp Bexsero® Trumenba® Meningococcal serogroup A, B, C, W, Y vaccine MenACWY-TT/ MenB-FHbp Penbraya™ Mpox vaccine Mpox Jynneos® Pneumococcal conjugate vaccine PCV15 PCV20 Vaxneuvance™ Prevnar 20™ Pneumococcal polysaccharide vaccine PPSV23 Pneumovax 23® Poliovirus vaccine IPV Ipol® RSV Arexvy® Abrysvo™ COVID-19 vaccine Respiratory syncytial virus vaccine Tetanus and diphtheria toxoids Td Tenivac® Tdvax™ Tetanus and diphtheria toxoids and acellular pertussis vaccine Tdap Adacel® Boostrix® Varicella vaccine VAR Varivax® Zoster vaccine, recombinant RZV Shingrix 1 Determine recommended vaccinations by age (Table 1) 2 Assess need for additional recommended vaccinations by medical condition or other indication (Table 2) 3 Review vaccine types, dosing frequencies and intervals, and considerations for special situations (Notes) 4 Review contraindications and precautions for vaccine types (Appendix) 5 Review new or updated ACIP guidance (Addendum) Recommended by the Advisory Committee on Immunization Practices (www.cdc.gov/vaccines/ acip) and approved by the Centers for Disease Control and Prevention (www.cdc.gov), American College of Physicians (www.acponline.org), American Academy of Family Physicians (www.aafp. org), American College of Obstetricians and Gynecologists (www.acog.org), American College of Nurse-Midwives (www.midwife.org), American Academy of Physician Associates (www.aapa. org), American Pharmacists Association (www.pharmacist.com), and Society for Healthcare Epidemiology of America (www.shea-online.org). y Suspected cases of reportable vaccine-preventable diseases or outbreaks to the local or state health department www.vaers.hhs.gov or 800‑822‑7967 Questions or comments Contact www.cdc.gov/cdc-info or 800-CDC-INFO (800-232-4636), in English or Spanish, 8 a.m.–8 p.m. ET, Monday through Friday, excluding holidays. Download the CDC Vaccine Schedules app for providers at www.cdc.gov/vaccines/schedules/hcp/schedule-app.html. Helpful information y Complete Advisory Committee on Immunization Practices (ACIP) recommendations: www.cdc.gov/vaccines/hcp/acip-recs/index.html y ACIP Shared Clinical Decision-Making Recommendations: www.cdc.gov/vaccines/acip/acip-scdm-faqs.html y General Best Practice Guidelines for Immunization www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html y Vaccine information statements: www.cdc.gov/vaccines/hcp/vis/index.html y Manual for the Surveillance of Vaccine-Preventable Diseases (including case identification and outbreak response): www.cdc.gov/vaccines/pubs/surv-manual Scan QR code for access to online schedule *Administer recommended vaccines if vaccination history is incomplete or unknown. Do not restart or add doses to vaccine series if there are extended intervals between doses. The use of trade names is for identification purposes only and does not imply endorsement by the ACIP or CDC. 12/28/2023 CS310021-D Table 1 Recommended Adult Immunization Schedule by Age Group, United States, 2024 Vaccine 19–26 years 27–49 years COVID-19 Influenza inactivated (IIV4) or Influenza recombinant (RIV4) 1 dose annually or or 1 dose annually Respiratory Syncytial Virus (RSV) Seasonal administration during pregnancy. See Notes. >60 years 1 dose Tdap each pregnancy; 1 dose Td/Tdap for wound management (see notes) Tetanus, diphtheria, pertussis (Tdap or Td) 1 dose Tdap, then Td or Tdap booster every 10 years Measles, mumps, rubella (MMR) 1 or 2 doses depending on indication (if born in 1957 or later) Varicella (VAR) Human papillomavirus (HPV) ≥65 years 1 or more doses of updated (2023–2024 Formula) vaccine (See Notes) Influenza live, attenuated (LAIV4) Zoster recombinant (RZV) 50–64 years 2 doses (if born in 1980 or later) 2 doses 2 doses for immunocompromising conditions (see notes) 2 or 3 doses depending on age at initial vaccination or condition For healthcare personnel, see notes 2 doses 27 through 45 years See Notes Pneumococcal (PCV15, PCV20, PPSV23) See Notes Hepatitis A (HepA) 2, 3, or 4 doses depending on vaccine Hepatitis B (HepB) 2, 3, or 4 or doses depending on vaccine or condition 2, 3, or 4 doses depending on vaccine condition Meningococcal A, C, W, Y (MenACWY) Meningococcal B (MenB) 1 or 2 doses depending on indication, see notes for booster recommendations 19 through 23 years 2 or 3 doses depending on vaccine and indication, see notes for booster recommendations Haemophilus influenzae type b (Hib) 1 or 3 doses depending on indication Mpox   ecommended vaccination for adults who meet age requirement, R lack documentation of vaccination, or lack evidence of immunity  Recommended vaccination for adults with an additional risk factor or another indication  Recommended vaccination based on shared clinical decision-making  No recommendation/ Not applicable Table 2 Recommended Adult Immunization Schedule by Medical Condition or Other Indication, United States, 2024 Always use this table in conjunction with Table 1 and the Notes that follow. Medical conditions or indications are often not mutually exclusive. If multiple medical conditions or indications are present, refer to guidance in all relevant columns. See Notes for medical conditions or indications not listed. VACCINE HIV infection CD4 percentage and count Immunocompromised (excluding HIV infection) Pregnancy COVID-19